Erlotinib Hydrochloride Powder CAS 183319-69-9 Antitumor Erlotinib HCl

• Customization: Available
• Powder: Yes
• Customized: Customized
• Certification: GMP, ISO 9001, USP
• Suitable for: Adult
• State: Powder
• Purity: >99%
• Sample: Available
• OEM: Available
• MOQ: 1kg
• CAS: 183319-69-9
• Keyword: Erlotinib Hydrochloride
• Keyword 1: Erlotinib HCl Powder
• Transport Package: 1kg Foil Bag /25kg Drum
• Specification: 99%
• Trademark: /
• Origin: China
• Production Capacity: 20000

Product Description

Product Description

Description

Erlotinib hydrochlorate is a small molecule tyrosine kinase inhibitor which acts reversibly on epidermal gf receptors, a hydrochloride of erlotinib, a molecular-targeted drug. 

It is mainly used as a second- or third-line treatment for locally advanced or metstatic non-small cell lung cancer (NSCLC) and as a treatment for pancreatic cancer. It is used as a tyrosine inhibitor for NSCLC treatment.

Product name	Erlotinib Hydrochloride
Appearance	white Powder
Specification	99%
Shelf life	2 years when properly stored

Function and Application

1. Erlotinib hydrochloride is a kind of small molecule epidermal gf receptor tyrosine kinase reversible inhibitor. It is mainly used for the second-line or third-line treatment of locally advanced or metastatic non-small cell lung cancer and for the treatment of pancreatic cancer.

2. HER-1/EGFR tyrosine kinase inhibitors.